Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
Korro Bio, Inc.
| Metric | Korro Bio, Inc. KRROHealthcare |
|---|---|
| Quality Score | 68 / 100 |
| Revenue (latest) | $6M |
| Net income (latest) | −$117M |
| Operating margin | −1906.4% |
| Net margin | −1834.5% |
| Return on equity | −228.0% |
| Return on assets | −103.3% |
| Return on capital (ROCE) | −120.0% |
| Debt / equity | 1.21× |
| Revenue growth (YoY) | 181.5% |
| Altman Z″ (distress) | -13.30 |
| Accruals / assets | −34.1% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.